Heritage Oak Wealth Advisors LLC Buys New Position in iShares U.S. Pharmaceuticals ETF $IHE

Heritage Oak Wealth Advisors LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 6,117 shares of the company’s stock, valued at approximately $530,000. Heritage Oak Wealth Advisors LLC owned 0.06% of iShares U.S. Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Hudock Inc. boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 3.9% in the 4th quarter. Hudock Inc. now owns 3,034 shares of the company’s stock valued at $257,000 after purchasing an additional 114 shares during the last quarter. O Shaughnessy Asset Management LLC raised its stake in iShares U.S. Pharmaceuticals ETF by 35.0% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock worth $39,000 after buying an additional 120 shares during the last quarter. National Bank of Canada FI raised its stake in iShares U.S. Pharmaceuticals ETF by 42.7% during the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock worth $42,000 after buying an additional 175 shares during the last quarter. Root Financial Partners LLC lifted its holdings in iShares U.S. Pharmaceuticals ETF by 36.5% in the first quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock valued at $60,000 after buying an additional 186 shares during the period. Finally, Corient Private Wealth LLC lifted its holdings in iShares U.S. Pharmaceuticals ETF by 3.1% in the fourth quarter. Corient Private Wealth LLC now owns 6,506 shares of the company’s stock valued at $552,000 after buying an additional 198 shares during the period.

iShares U.S. Pharmaceuticals ETF Trading Down 0.7%

Shares of IHE opened at $98.29 on Thursday. The firm’s fifty day simple moving average is $91.12 and its two-hundred day simple moving average is $88.56. iShares U.S. Pharmaceuticals ETF has a 12 month low of $64.94 and a 12 month high of $100.37. The stock has a market capitalization of $1.11 billion, a P/E ratio of 17.75 and a beta of 0.49.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.